0001214659-22-010296.txt : 20220816 0001214659-22-010296.hdr.sgml : 20220816 20220816161553 ACCESSION NUMBER: 0001214659-22-010296 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220812 FILED AS OF DATE: 20220816 DATE AS OF CHANGE: 20220816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARTER BRUCE L A CENTRAL INDEX KEY: 0001225503 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 221170351 MAIL ADDRESS: STREET 1: C/O ZYMOGENETICS, INC. STREET 2: 1201 EASTLAKE AVENUE CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3545 CRAY COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 3545 CRAY COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-56893.xml PRIMARY DOCUMENT X0306 4 2022-08-12 0001576263 Mirati Therapeutics, Inc. MRTX 0001225503 CARTER BRUCE L A C/O MIRATI THERAPEUTICS, INC 3545 CRAY COURT SAN DIEGO CA 92121 true false false false Common Stock 2022-08-12 4 M false 10000 27.00 A 16021 D Common Stock 2022-08-12 4 S false 5107 85.0376 D 10914 D Common Stock 2022-08-12 4 S false 4893 85.962 D 6021 D Non Qualified Stock Option (right to buy) 27.00 2022-08-12 4 M false 10000 0.00 D 2028-01-17 Common Stock 10000 0 D This transaction was executed in multiple trades at prices ranging from $84.55 to $85.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $85.60 to $86.555. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The shares subject to the Option vested and became exercisable in 12 equal monthly installments following the date of grant. /s/Reena Desai, Attorney-in-Fact 2022-08-16